LIPERTANCE

10MG/5MG/5MG TBL FLM 30

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 01.09.2020
Interruption of marketing 18.08.2020 0205993
Manufacturing reasons 31.08.2020
Interruption of marketing 10.08.2020 0205993
Manufacturing reasons 18.08.2020
Interruption of marketing 09.07.2020 0205993
Manufacturing reasons 10.08.2020
Resumption of marketing 30.05.2020
Interruption of marketing 01.04.2020 0205993
Capacity/distribution reasons 30.06.2020
Placing on the market 15.09.2016

All reports are available in the Overview.

Back to list